D. Nathan

发表

Dependence of highly enriched human bone marrow progenitors on hemopoietic growth factors and their response to recombinant erythropoietin.

A. Mufson, C. Sieff, S. Emerson, 1986, The Journal of clinical investigation.

Clinical research and the NIH--a report card.

D. Nathan, Jean D. Wilson, 2003, The New England journal of medicine.

The passage of ammonia across the blood-brain-barrier and its relation to blood pH.

K. Warren, D. Nathan, 1958, Journal of Clinical Investigation.

The acute and transient nature of idiopathic immune hemolytic anemia in childhood.

D. Nathan, L. Boxer, G. Buchanan, 1976, Jornal de Pediatria.

Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia.

S. Orkin, O. Platt, G. P. Beardsley, 1984, The Journal of clinical investigation.

Acute Hemodynamic Effects of Red Cell Volume Reduction in Polycythemia of Cyanotic Congenital Heart Disease

A. Marty, A. Rosenthal, A. Nadas, 1970, Circulation.

Transfusion management of sickle cell disease.

D. Nathan, A. Wayne, S. Kevy, 1993, Blood.

Beta-thalassemia due to two novel nucleotide substitutions in consensus acceptor splice sequences of the beta-globin gene.

S. Orkin, S. Antonarakis, D. Nathan, 1989, Blood.

One-day ex vivo culture allows effective gene transfer into human nonobese diabetic/severe combined immune-deficient repopulating cells using high-titer vesicular stomatitis virus G protein pseudotyped retrovirus.

R. Mulligan, Jeng-Shin Lee, D. Nathan, 1999, Blood.

R. Mulligan, D. Nathan, M. Tanaka, 1999, Blood.

Effects of urea and cyanate on sickling in vitro.

S. Shohet, D. Nathan, H. Bunn, 1972, The New England journal of medicine.

Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse

David A. Williams, R. Mulligan, I. Lemischka, 1984, Nature.

Development of an effective treatment program for childhood acute lymphocytic leukemia: a preliminary report.

S. Sallan, J. Cassady, D. Nathan, 1976, Medical and pediatric oncology.

Intermittent combination chemotherapy with adriamycin for childhood acute lymphoblastic leukemia: clinical results.

S. Sallan, J. Cassady, D. Nathan, 1978, Blood.

Changes in fatty acid metabolism after erythrocyte peroxidation: stimulation of a membrane repair process.

S. Shohet, D. Nathan, B. Lubin, 1972, The Journal of clinical investigation.

The Genetic Landscape of Diamond-Blackfan Anemia

Beryl B. Cummings, Jacob C. Ulirsch, Michael H. Guo, 2018, bioRxiv.

The Genetic Landscape of Diamond-Blackfan Anemia

S. Gabriel, R. Handsaker, E. Lander, 2018, bioRxiv.

RNA and protein evidence for haplo‐insufficiency in Diamond–Blackfan anaemia patients with RPS19 mutations

W. Wiktor-Jedrzejczak, J. Zaucha, A. Beggs, 2004, British journal of haematology.

Diamond-Blackfan anemia. Natural history and sequelae of treatment.

E. Guinan, D. Nathan, A. Janov, 1996, Medicine.

A functional isoform of the human granulocyte/macrophage colony-stimulating factor receptor has an unusual cytoplasmic domain.

B. Mathey-Prevot, C. Sieff, D. Nathan, 1991, Proceedings of the National Academy of Sciences of the United States of America.

The childhood leukemias.

S. Sallan, D. Nathan, H. Weinstein, 1981, The Journal of pediatrics.

Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson.

D. Neuberg, O. Onyekwere, J. Keefer, 2013, Blood.

A Phase I Single Ascending Dose Study Of NKTT120 In Stable Adult Sickle Cell Patients

R. Mashal, K. Ataga, C. Eaton, 2013 .

Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease.

D. Neuberg, V. Gordeuk, J. Linden, 2017, Blood advances.

GLOBIN TRANSLATION IN THALASSEMIC BONE MARROW *

H. Lodish, D. Nathan, G. Cividalli, 1974, Annals of the New York Academy of Sciences.

Hydroxyurea-induced HbF production in anemic primates: augmentation by erythropoietin, hematopoietic growth factors, and sodium butyrate.

A. Nienhuis, K. McDonagh, R. Donahue, 1992, Experimental hematology.

Acceptance of the 2003 John Howland Award: A Journey in Clinical Research

D. Nathan, 2004, Pediatric Research.

Cation permeability alterations during sickling: relationship to cation composition and cellular hydration of irreversibly sickled cells

B. Glader, D. Nathan, 1978 .

Cation permeability alterations during sickling: relationship to cation composition and cellular hydration of irreversibly sickled cells.

B. Glader, D. Nathan, 1978, Blood.

Positive and negative elements regulate human interleukin 3 expression.

N. Andrews, B. Mathey-Prevot, D. Nathan, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Cooperation between Core Binding Factor and Adjacent Promoter Elements Contributes to the Tissue-specific Expression of Interleukin-3*

J. Laubach, B. Mathey-Prevot, D. Nathan, 1996, The Journal of Biological Chemistry.

Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromes.

J. Lipton, D. Nathan, B. Smith, 1985, Blood.

A novel diagnostic screen for defects in the Fanconi anemia pathway.

A. D’Andrea, R. Montes de Oca, A. Shimamura, 2002, Blood.

Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of pancytopenia in children with fanconi anemia.

E. Guinan, D. Nathan, J. Felser, 1994, The Journal of pediatrics.

The molecular basis of α-thalassemias: Frequent occurrence of dysfunctional α loci among non-Asians with Hb H disease

H. Lazarus, S. Orkin, D. Weatherall, 1979, Cell.

Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major.

S. Colan, M. Freedman, N. Olivieri, 1985, The New England journal of medicine.

Expression of human interleukin-3 (multi-CSF) is restricted to human lymphocytes and T-cell tumor lines.

C. Niemeyer, B. Bierer, B. Mathey-Prevot, 1989, Blood.

Nathan and Oski's hematology and oncology of infancy and childhood /

A. Look, S. Orkin, D. Ginsburg, 2015 .

New approaches to the transfusion management of thalassemia

D. Nathan, L. Button, R. Propper, 1980 .

New approaches to the transfusion management of thalassemia.

D. Nathan, L. Button, R. Propper, 1980, Blood.

Musings on genome medicine: cancer genetics and the promise of effective treatment

S. Orkin, D. Nathan, 2009, Genome Medicine.

The cancer treatment revolution.

D. Nathan, 2007, Transactions of the American Clinical and Climatological Association.

Targeting the Cell Death-Survival Equation

N. Danial, R. Amaravadi, D. Nathan, 2007, Clinical Cancer Research.

Human IL-3 and GM-CSF act synergistically in stimulating hematopoiesis in primates.

P. Sehgal, R. Donahue, M. Metzger, 1988, Science.

Therapy-linked leukemia.

F. Li, D. Nathan, A. Walker, 1971, British medical journal.

The molecular basis of alpha-thalassemias: frequent occurrence of dysfunctional alpha loci among non-Asians with Hb H disease.

H. Lazarus, S. Orkin, D. Weatherall, 1979, Cell.

Monocytes do not inhibit peripheral blood erythroid burst forming unit colony formation.

J. Lipton, D. Nathan, J. Bréard, 1980, The Journal of clinical investigation.

Mature bone marrow erythroid burst-forming units do not require T cells for induction of erythropoietin-dependent differentiation

E. Reinherz, J. Lipton, D. Nathan, 1980, The Journal of experimental medicine.

Pathophysiology and Clinical Manifestations of the b -Thalassemias

A. Nienhuis, D. Nathan, 2012 .

Pathophysiology and Clinical Manifestations of the β-Thalassemias.

A. Nienhuis, D. Nathan, 2012, Cold Spring Harbor perspectives in medicine.

Musings on genome medicine: cholesterol and coronary artery disease

S. Orkin, D. Nathan, 2009, Genome Medicine.

The mortality of acquired aplastic anemia in children.

F. Li, B. Alter, D. Nathan, 1972, Blood.

Improved prognosis for patients with mediastinal lymphoblastic lymphoma.

N. Jaffe, J. Cassady, D. Nathan, 1979, Blood.

Clinical removal of iron.

D. Nathan, R. Propper, 1982, Annual review of medicine.

A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia.

R. Storb, R. Gale, K. Kopecky, 1979, Blood.

The beta chain of the interleukin-3 receptor functionally associates with the erythropoietin receptor.

J. Tavernier, D. Nathan, P. Jubinsky, 1997, Blood.

The βc Component of the Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)/Interleukin 3 (IL-3)/IL-5 Receptor Interacts with a Hybrid GM-CSF/Erythropoietin Receptor to Influence Proliferation and β-Globin mRNA Expression

M. Carroll, D. Nathan, P. Jubinsky, 1996, Molecular Medicine.

Thalassemia: the continued challenge.

D. Nathan, 2009, Annals of the New York Academy of Sciences.

Continuous Subcutaneous Administration of Deferoxamine in Patients with Iron Overload

W. Anderson, A. Nienhuis, B. Cooper, 1977 .

Thalassemia: a look to the future

D. Nathan, D. G. Nathan, 2016, Annals of the New York Academy of Sciences.

A non‐human primate model for the study of oral iron chelators

R. Nicolosi, D. Nathan, L. Wolfe, 1989, British journal of haematology.

Gallium-67 scintigraphy in children with chronic granulomatous disease

S. Treves, D. Nathan, N. Papanicolaou, 2005, Pediatric Radiology.

Indium Chloride Scintigraphy: An Index of Severity in Patients with Aplastic Anaemia

B. McNeil, D. Nathan, J. Rappeport, 1976, British journal of haematology.

Inhibition of hemoglobin synthesis by cyanate in vitro.

Y. Kan, B. Alter, D. Nathan, 1974, Blood.

Expression and function of the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit.

D. Nathan, C. Sieff, A. Laurie, 1994, Blood.

A physician or group of physicians considers presentation and evolution of a real clinical case, reacting to clinical information and data (boldface type). This is followed by a discussion/commentary Hereditary xerocytosis revisited

M. Fleming, D. Vandorpe, F. Sachs, 2014 .

Hereditary xerocytosis revisited

D. Vandorpe, F. Sachs, A. Iolascon, 2014, American journal of hematology.

Effects of erythroid hyperplasia on patterns of glycine-2-C-14 uptake in heme and globin of human peripheral blood in vivo.

D. Nathan, F. Gardner, 1966, Blood.

THE METABOLISM OF THE INDIVIDUAL C14 LABELED HEMOGLOBINS IN PATIENTS WITH H-THALASSEMIA, WITH OBSERVATIONS ON RADIOCHROMATE BINDING TO THE HEMOGLOBINS DURING RED CELL SURVIVAL.

D. Nathan, F. Gardner, T. Gabuzda, 1965, The Journal of clinical investigation.

THE TURNOVER OF HEMOGLOBINS A, F, AND A(2) IN THE PERIPHERAL BLOOD OF THREE PATIENTS WITH THALASSEMIA.

D. Nathan, F. Gardner, T. Gabuzda, 1963, The Journal of clinical investigation.

Comparative Metabolism of Hæmoglobins A and F in Thalassæmia

D. Nathan, F. Gardner, T. Gabuzda, 1962, Nature.

Defective erythroid progenitor differentiation system in congenital hypoplastic (Diamond-Blackfan) anemia.

J. Lipton, D. Nathan, R. Gross, 1986, Blood.

Energy metabolism in human erythrocytes. I. Effects of sodium fluoride.

S. Shohet, D. Nathan, S. Feig, 1971, The Journal of clinical investigation.

Perceptions, Reality, and Proposed Solutions

D. Nathan, 2016 .

The several Cs of translational clinical research.

D. Nathan, 2005, The Journal of clinical investigation.

Clinical Research: Perceptions, Reality, and Proposed Solutions

D. Nathan, 1998 .

Expression and Function of the Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor

Laurie, Andrew, D. Nathan, 2002 .

A low-affinity human granulocyte-macrophage colony-stimulating factor/murine erythropoietin hybrid receptor functions in murine cell lines.

C. Sieff, D. Nathan, D. Wilson, 1993, Blood.

Influence of hemoglobin precipitation on erythrocyte metabolism in alpha and beta thalassemia.

R. Gunn, D. Nathan, H. Zarkowsky, 1969, The Journal of clinical investigation.

Leukocyte Oxidase: Defective Activity in Chronic Granulomatous Disease

D. Nathan, R. Baehner, 1967, Science.

cells stimulated with hematopoietic growth factors colony- stimulating factor receptor subunits in murine hematopoietic Enhanced expression of interleukin-3 and granulocyte-macrophage

N. Andrews, B. Mathey-Prevot, D. Nathan, 2013 .

Enhanced expression of interleukin-3 and granulocyte-macrophage colony-stimulating factor receptor subunits in murine hematopoietic cells stimulated with hematopoietic growth factors.

N. Andrews, B. Mathey-Prevot, D. Nathan, 1992, Blood.

Successful use of multiagent immunosuppression in the bone marrow transplantation of sensitized patients.

D. Nathan, B. Camitta, J. Rappeport, 1978, Blood.

Evidence for genetic restriction in the suppression of erythropoiesis by a unique subset of T lymphocytes in man.

L. Nadler, J. Lipton, D. Nathan, 1983, The Journal of clinical investigation.

The effect of desferrithiocin, an oral iron chelator, on T-cell function.

B. Bierer, D. Nathan, D. G. Nathan, 1990, Blood.

Heterogeneity of DNA deletion in gamma delta beta-thalassemia.

S. Orkin, D. Nathan, S. C. Goff, 1981, The Journal of clinical investigation.

Recapitulation of the immune response and haematopoietic system in bone marrow transplantation.

J. Lipton, D. Nathan, S. Burakoff, 1983, Clinics in haematology.

The relationship of total red cell volume to total body water in octogenarian males.

S. Piomelli, D. Nathan, F. Gardner, 1962, Blood.

Fetal hemoglobin levels and morbidity in untransfused patients with β-thalassemia intermedia.

M. Cappellini, A. Taher, V. Sankaran, 2012, Blood.

Reassessment of the use of desferrioxamine B in iron overload.

S. Shurin, D. Nathan, R. Propper, 1976, The New England journal of medicine.

Purification of fetal hematopoietic progenitors and demonstration of recombinant multipotential colony-stimulating activity.

S. Clark, C. Sieff, S. Emerson, 1985, The Journal of clinical investigation.

Partial deletion of beta-globin gene DNA in certain patients with beta 0-thalassemia.

S. Orkin, D. Weatherall, D. Nathan, 1979, Proceedings of the National Academy of Sciences of the United States of America.

Rapid Publication Hydroxyurea Enhances Fetal Hemoglobin Production in Sickle Cell Anemia

S. Orkin, G. P. Beardsley, D. Nathan, 2013 .

Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation.

J. Belli, R. Geha, F. Rosen, 1978, The New England journal of medicine.

Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality.

R. Storb, R. Gale, D. Nathan, 1976, Blood.

Editorial: NBT reduction by human phagocytes.

D. Nathan, 1974, New England Journal of Medicine.

Anemia in adolescence. 1. Disturbances of iron balance.

D. Nathan, B. Camitta, 1975, Postgraduate medicine.

NNKTT120, an anti-iNKT cell monoclonal antibody, produces rapid and sustained iNKT cell depletion in adults with sickle cell disease

R. Mashal, K. Ataga, E. Vichinsky, 2017, PloS one.

Human recombinant granulocyte-macrophage colony-stimulating factor: a multilineage hematopoietin.

R. Donahue, S. Clark, C. Sieff, 1985, Science.

Treatment of iron overload in adults with continuous parenteral desferrioxamine.

D. Rosenthal, D. Nathan, H. Bunn, 1977, The American journal of medicine.

COVID-19, nuclear war, and global warming: lessons for our vulnerable world

D. Nathan, J. Muller, 2020, The Lancet.

Combinations of recombinant colony-stimulating factors are required for optimal hematopoietic differentiation in serum-deprived culture.

C. Sieff, D. Nathan, S. Ekern, 1989, Blood.

Stimulation of human hematopoietic colony formation by recombinant gibbon multi-colony-stimulating factor or interleukin 3.

F. Bieber, C. Niemeyer, S. Clark, 1987, The Journal of clinical investigation.

PEDIATRIC BONE MARROW TRANSPLANTATION-A BIO-ETHICAL MODEL

W. Curran, D. Nathan, B. Camitta, 1974, Pediatric Research.

Thalassemia: The Continued Challenge

D. Nathan, 2005 .

Heterogeneity of DNA Deletion in y8,6-Thalassemia

S. Orkin, D. Nathan, 2003 .

Molecular analysis of the high-hemoglobin-F phenotype in Saudi Arabian sickle cell anemia.

S. Orkin, N. Olivieri, D. Nathan, 1987, The New England journal of medicine.

Regulation of fetal hemoglobin synthesis in sickle cell anemia.

D. Nathan, 1987, Transactions of the American Clinical and Climatological Association.

Hematology of Infancy and Childhood

F. Oski, D. Nathan, 1974 .

Antenatal Diagnosis of the Haemoglobinopathies

B. Alter, D. Nathan, 1975, Lancet.

Effect of transfusional iron intake on response to chelation therapy in β-thalassemia major. Commentary

E. Glimm, D. Nathan, A. Cohen, 2008 .

Pathophysiology of the Anaemia in Thalassaemia

D. Nathan, E. Benz, 2008 .

Thalassemia: a progress report in applied molecular biology.

D. Nathan, 1973, New England Journal of Medicine.

Equal synthesis of - and -globin chains in erythroid precursors in heterozygous -thalassemia.

H. Lodish, Y. Kan, D. Nathan, 1972, The Journal of clinical investigation.

Mild thalassemia: the result of interactions of alpha and beta thalassemia genes.

Y. Kan, D. Nathan, 1970, The Journal of clinical investigation.

Analysis of hemoglobin F production in Saudi Arabian families with sickle cell anemia.

S. Orkin, N. Olivieri, D. Nathan, 1987, Blood.

Beta thalassemia and translation of globin messenger RNA.

H. Lodish, D. Housman, Y. Kan, 1971, Proceedings of the National Academy of Sciences of the United States of America.

Saudi Arabian Sickle Cell Anemia a

S. Orkin, N. Olivieri, D. Nathan, 1989, Annals of the New York Academy of Sciences.

CELL‐CELL INTERACTIONS IN THE REGULATION OF ERYTHROPOIESIS

J. Lipton, D. Nathan, 1983, British journal of haematology.

Stages in the incorporation of fatty acids into red blood cells.

S. Shohet, D. Nathan, M. L. Karnovsky, 1968, The Journal of clinical investigation.

Prenatal diagnosis of hemoglobinopathies. A review of 15 cases.

J. Hobbins, B. Alter, D. Nathan, 1976, The New England journal of medicine.

Gamma-beta thalassemia: a cause of hemolytic disease of the newborn.

Y. Kan, D. Nathan, B. Forget, 1972, The New England journal of medicine.

New developments in iron chelators

D. Nathan, M. Cunningham, Melody J. Cunningham, 2005, Current opinion in hematology.

Key Learning from the Dana-Farber Cancer Institute's 10-Year Patient Safety Journey

S. Sallan, S. Weingart, L. Shulman, 2006 .

Identification of three accessory cell populations in human bone marrow with erythroid burst-promoting properties.

J. Lipton, D. Nathan, D. Linch, 1985, The Journal of clinical investigation.

Identification of three accessory cell populations in human bone marrow with erythroid burst promoting properties.

D. Nathan, D. C. Linch, Jeffrey M. Lipton, 1985, Progress in clinical and biological research.

Aplastic and hypoplastic anemia.

J. Lipton, D. Nathan, 1980, The Pediatric clinics of North America.

Correction of metabolic deficiencies in the leukocytes of patients with chronic granulomatous disease.

D. Nathan, M. L. Karnovsky, R. Baehner, 1970, The Journal of clinical investigation.

The dependence of highly enriched bone marrow progenitors on hematopoietic growth factors and their response to recombinant erythropoietin

A. Mufson, C. Sieff, S. Emerson, 2017 .

Energy metabolism in human erythrocytes. II. Effects of glucose depletion.

S. Shohet, D. Nathan, G. Segel, 1972, The Journal of clinical investigation.

Hematopoiesis in vitro coexists with natural killer lymphocytes.

C. Niemeyer, D. Nathan, C. Sieff, 1989, Blood.

Demonstration of burst-promoting activity of recombinant human GM-CSF on circulating erythroid progenitors using an assay involving the delayed addition of erythropoietin.

R. Donahue, S. Clark, S. Emerson, 1985, Blood.

Diamond Blackfan anemia treatment: past, present, and future.

D. Nathan, A. Narla, A. Vlachos, 2011, Seminars in hematology.

Globin chain synthesis in the alpha thalassemia syndromes.

Y. Kan, D. Nathan, E. Schwartz, 1968, The Journal of clinical investigation.

The role of adenosine signaling in sickle cell therapeutics.

J. Linden, D. Nathan, Joshua J Field, 2014, Hematology/oncology clinics of North America.

Differential binding of erythroid and myeloid progenitors to fibroblasts and fibronectin

H. Lodish, S. Tsai, D. Nathan, 1987 .

Busulfan and total body irradiation as antihematopoietic stem cell agents in the preparation of patients with congenital bone marrow disorders for allogenic bone marrow transplantation.

R. Geha, S. Hellman, J. Lipton, 1984, Blood.

Allogeneic bone marrow transplantation for chronic granulomatous disease.

R. Goldblum, P. Newburger, D. Nathan, 1982, The Journal of pediatrics.

Targeting iNKT cells for the treatment of sickle cell disease.

J. Linden, D. Nathan, Joshua J Field, 2011, Clinical immunology.

Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model.

S. Karlsson, W. Anderson, A. Nienhuis, 1987, The Journal of clinical investigation.

In vitro treatment with monoclonal antibody prior to autologous bone marrow transplantation in acute lymphoblastic leukemia.

R. Bast, J. Ritz, S. Sallan, 1983, Haematology and blood transfusion.

Advances in Sickle Cell Therapies in the Hydroxyurea Era

D. Nathan, Joshua J Field, 2014, Molecular medicine.

Fluorometric analysis of glycolytic intermediates and pyridine nucleotides in peripheral blood cells.

D. Nathan, G. Segel, S. Feig, 1971, Journal of Laboratory and Clinical Medicine.

Guilt by association.

D. Nathan, 2011, Blood.

Musings on genome medicine: gene therapy

S. Orkin, D. Nathan, 2009, Genome Medicine.

Oxidant injury of caucasian glucose-6-phosphate dehydrogenase-deficient red blood cells by phagocytosing leukocytes during infection.

D. Nathan, W. Castle, R. Baehner, 1971, The Journal of clinical investigation.

Deferiprone and hepatic fibrosis.

G. Brittenham, D. Weatherall, E. Vichinsky, 2003, Blood.

Stromal cell-associated erythropoiesis.

S. Tsai, C. Sieff, D. Nathan, 1986, Blood.

PERSPECTIVE Treatment of Cooley’s Anemia

D. Nathan, Martin, Fosburg, 2003 .

Disorders of phagocytic cell function.

D. Nathan, R. Baehner, 1971, Progress in hematology.

THE JEREMIAH METZGER LECTURE.

D. Nathan, 2016, Transactions of the American Clinical and Climatological Association.

Regulation of Hematopoiesis

D. Nathan, 1990, Pediatric Research.

NF-κB Is Activated in CD4+ iNKT Cells by Sickle Cell Disease and Mediates Rapid Induction of Adenosine A2A Receptors

D. Neuberg, J. Linden, D. Nathan, 2013, PloS one.

Failure of nitro blue tetrazolium reduction in the phagocytic vacuoles of leukocytes in chronic granulomatous disease.

D. Nathan, R. Baehner, D. Weaver, 1969, The Journal of clinical investigation.

Differential binding of erythroid and myeloid progenitors to fibroblasts and fibronectin.

H. Lodish, S. Tsai, D. Nathan, 1987, Blood.

Blood volume changes in cyanotic congenital heart disease.

A. Rosenthal, A. Nadas, D. Nathan, 1971, American Journal of Cardiology.

Hereditary hemolytic anemia associated with abnormal membrane lipid. II. Ion permeability and transport abnormalities.

S. Shohet, D. Nathan, E. Jaffé, 1973, Blood.

Congenital methemoglobinemia: the result of age-dependent decay of methemoglobin reductase.

D. Nathan, S. Feig, P. Gerald, 1972, Blood.

Hereditary hemolytic anemia associated with abnormal membrane lipids: mechanism of accumulation of phosphatidyl choline.

S. Shohet, D. Nathan, E. Jaffé, 1971, Blood.

Effects of large doses of androgen on rodent erythropoiesis and body composition.

D. Nathan, F. Gardner, D. G. Nathan, 1965, Blood.

Cholesterol: the debate should be terminated

D. Nathan, David G. Nathan, 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

A phase I/II trial of recombinant granulocyte-macrophage colony-stimulating factor for children with aplastic anemia.

E. Guinan, C. Sieff, D. Nathan, 1990, Blood.

ERYTHROPOIESIS IN ANEPHRIC MAN.

D. Nathan, J. Merrill, E. Schupak, 1964, The Journal of clinical investigation.

Selection of patients for bone marrow transplantation in severe aplastic anemia.

D. Nathan, B. Camitta, J. Rappeport, 1975, Blood.

Posthepatitic severe aplastic anemia--an indication for early bone marrow transplantation.

D. Nathan, B. Camitta, J. Rappeport, 1974, Blood.

Effects of interleukin-3 and granulocyte-macrophage colony-stimulating factor on thrombopoiesis in congenital amegakaryocytic thrombocytopenia

E. Guinan, R. Hoffman, D. Nathan, 1993 .

Effects of interleukin-3 and granulocyte-macrophage colony-stimulating factor on thrombopoiesis in congenital amegakaryocytic thrombocytopenia.

Dagmar, E. Guinan, R. Hoffman, 1993, Blood.

Erythrocyte ion transport defects and hemolytic anemia: "hydrocytosis" and "desiccytosis".

S. Shohet, D. Nathan, 1970, Seminars in hematology (Print).

NKTT120 Reduces iNKT Cells without Dose Limiting Toxicity in Stable Adult Sickle Cell Patients in a Phase 1 Trial

K. Ataga, E. Vichinsky, C. Eaton, 2014 .

The treatment of Cooley's anemia.

D. Nathan, D. Nathan, 1990, Haematologica.

Splenectomy in the Wiskott-Aldrich syndrome.

D. Nathan, 1980, The New England journal of medicine.

THALASSEMIA TRAIT. GENETIC COMBINATIONS OF INCREASED FETAL AND A2 HEMOGLOBINS.

D. Nathan, F. Gardner, T. Gabuzda, 1964, The New England journal of medicine.

allogenic bone marrow transplantation in the preparation of patients with congenital bone marrow disorders for Busulfan and total body irradiation as antihematopoietic stem cell agents

B. Smith, R. Geha, S. Hellman, 2013 .

Studies of the production and life span of erythrocytes in myeloid metaplasia.

D. Nathan, N. Berlin, 1959, Blood.

Reversing the hemoglobin switch.

V. Sankaran, D. Nathan, Vijay G Sankaran, 2010, The New England journal of medicine.

Genes, Blood, and Courage: A Boy Called Immortal Sword

D. Nathan, 1998, Nature Medicine.

PRENATAL DIAGNOSIS OF HEMOGLOBINOPATHIES: THE NEW ENGLAND APPROACH *

S. Orkin, B. Alter, D. Nathan, 1980, Annals of the New York Academy of Sciences.

Prenatal diagnosis of hemoglobinopathies.

S. Orkin, B. Alter, D. Nathan, 1979, Clinics in perinatology.

Fetal research: an investigator's view.

D. Nathan, 1977, Villanova law review.

Prenatal diagnosis of hemoglobinopathies: detection of alpha-thalassemia trait and of sickle cell disease in utero.

J. Hobbins, B. Alter, D. Nathan, 1977, Hemoglobin.

Antenatal diagnosis of hemoglobinopathies: an exquisite molecular brew.

D. Nathan, 1976, The New England journal of medicine.

Antenatal diagnosis of hemoglobinopathies: social and technical considerations.

B. Alter, D. Nathan, F. Frigoletto, 1975, Seminars in hematology.

Ethical problems in fetal research.

D. Nathan, 1975, The Journal of general education.

Progress in the methodology for antenatal diagnosis of the beta chain hemoglobinopathies.

D. Nathan, 1975, Transactions of the Association of American Physicians.

In utero diagnosis of: hemoglobinopathies. Hemoglobin synthesis in fetal red cells.

J. Hobbins, Y. Kan, D. Nathan, 1974, The New England journal of medicine.

Concentration of fetal red blood cells from a mixture of maternal and fetal blood by anti-i serum--an aid to prenatal diagnosis of hemoglobinopathies.

Y. Kan, D. Nathan, G. Cividalli, 1974, Blood.

Detection of the sickle gene in the human fetus. Potential for intrauterine diagnosis of sickle-cell anemia.

Y. Kan, B. Alter, D. Nathan, 1972, The New England journal of medicine.

Red cell aplasia in children.

B. Alter, D. Nathan, 1979, Archives of disease in childhood.

Musings on genome medicine: genome wide association studies

S. Orkin, D. Nathan, 2009, Genome Medicine.

Thalassemia: the consequences of unbalanced hemoglobin synthesis.

R. Gunn, D. Nathan, 1966, The American journal of medicine.

Energy Reserve and Cation Composition of Irreversibly Sickled Cell in Vivo

O. Platt, B. Glader, D. Nathan, 1978, British journal of haematology.

Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial

E. Neufeld, N. Olivieri, R. Grady, 2003, The Lancet.

A colorimetric procedure for the determination of blood ammonia.

F. Rodkey, D. Nathan, 1957, The Journal of laboratory and clinical medicine.

The effect of amphotericin B on erythrocyte membrane cation permeability: its relation to in vivo erythrocyte survival.

S. Shohet, D. Nathan, F. Gardner, 1969, The Journal of laboratory and clinical medicine.

Quantitative nitroblue tetrazolium test in chronic granulomatous disease.

D. Nathan, D G Nathan, R. Baehner, 1968, The New England journal of medicine.

Energy metabolism in human erythrocytes: the role of phosphoglycerate kinase in cation transport.

B. Glader, D. Nathan, G. Segel, 1975, Blood.

Influence of erythrocyte membrane adenosine triphosphatase on the metabolism of hemolysates.

D. Nathan, H. Zarkowsky, D. G. Nathan, 1970 .

Increased Susceptibility to Infection Due to Dysfunction of Granulocytes

D. Nathan, R. Baehner, 1970 .

Survival in Medically Treated Patients with Homozygous β-Thalassemia

J. H. MacMillan, G. Koren, N. Olivieri, 1994 .

Congenital hemolytic anemia with high sodium, low potassium red cells. I. Studies of membrane permeability.

F. Oski, S. Shohet, D. Nathan, 1968, The New England journal of medicine.

Efficacy of a short course (four doses) of methotrexate following bone marrow transplantation for prevention of graft-versus-host disease.

J. Lipton, D. Nathan, B. Smith, 1985, Transplantation.

Antithoracic duct lymphocyte globulin therapy of severe aplastic anemia.

R. Storb, R. Hoffmann, R. Gale, 1983, Blood.

Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement.

R. Bast, S. Sallan, J. Ritz, 1983, Cancer research.

Treatment of acute myelogenous leukemia in children and adults.

D. Rosenthal, R. Mayer, D. Nathan, 1980, The New England journal of medicine.

The red cell peroxide hemolysis test in the differential diagnosis of obstructive jaundice in the newborn period.

S. Shohet, D. Nathan, B. Lubin, 1971, Pediatrics.

Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF

P. Sehgal, R. Kamen, R. Donahue, 1986, Nature.

Academic careers: choice and activity of graduates of a pediatric residency program 1974-1986.

F. Lovejoy, F. Ledley, D. Nathan, 1993, Transactions of the American Clinical and Climatological Association.

Clinical research: a tale of two studies.

D. Nathan, 2003, Transactions of the American Clinical and Climatological Association.

Academic freedom in clinical research.

D. Weatherall, D. Nathan, David G Nathan, 2002, The New England journal of medicine.

An orally active iron chelator.

D. Nathan, 1995, The New England journal of medicine.

Endogenous production of carbon monoxide in normal and erythroblastotic newborn infants.

M. J. Maisels, D. Nathan, A. Pathak, 1971, The Journal of clinical investigation.

Erythroid cell maturation and hemoglobin synthesis in megaloblastic anemia.

D. Nathan, F. Gardner, 1962, The Journal of clinical investigation.

The synthesis of heme and globin in the maturing human erythroid cell.

S. Piomelli, D. Nathan, F. Gardner, 1961, The Journal of clinical investigation.

Selective reticulocyte destruction in erythrocyte pyruvate kinase deficiency.

D. Nathan, D G Nathan, W C Mentzer, 1971, The Journal of clinical investigation.

Hemoglobin Syracuse (alpha2beta2-143(H21)His leads to Pro), a new high-affinity variant detected by special electrophoretic methods. Observations on the auto-oxidation of normal and variant hemoglobins.

F. Oski, D. Nathan, H. Bunn, 1975, The Journal of clinical investigation.

Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia.

R. Gelber, S. Sallan, J. Cassady, 1983, Cancer research.

Fetal erythropoiesis following bone marrow transplantation.

B. Alter, D. Nathan, T. Huisman, 1976, Blood.

Detection of leukemia-related karyotypes in granulocyte/macrophage colonies from a patient with acute myelomonocytic leukemia.

J. Lipton, D. Nathan, H. Weinstein, 1983, The New England journal of medicine.

Iron Deficiency Anemia Associated with an Error of Iron Metabolism in Two Siblings: A Thirty Year Follow Up.

N. Andrews, M. Fleming, D. Nathan, 1996, Hematology.

IRON DEFICIENCY ANEMIA ASSOCIATED WITH AN ERROR OF IRON METABOLISM IN TWO SIBLINGS.

D. Nathan, L. Diamond, N. Shahidi, 1964, The Journal of clinical investigation.

Incorporation of phosphatide precursors from serum into erythrocytes.

S. Shohet, D. Nathan, 1970, Biochimica et biophysica acta.

Regulation of hemoglobin synthesis. Preferential inhibition of and globin synthesis.

H. Lodish, D. Nathan, 1972, The Journal of biological chemistry.

Search for improved therapy of sickle cell anemia.

D. Nathan, 2002, Journal of pediatric hematology/oncology.

Careers in translational clinical research-historical perspectives, future challenges.

D. Nathan, David G Nathan, 2002, JAMA.

Educational-debt relief for clinical investigators--a vote of confidence.

D. Nathan, 2002, The New England journal of medicine.

The National Institutes of Health and clinical research: a progress report

H. Varmus, D. Nathan, 2000, Nature Medicine.

High fetal hemoglobin production in sickle cell anemia in the eastern province of Saudi Arabia is genetically determined.

S. Orkin, D. Weatherall, D. Nathan, 1986, Blood.

High fetal hemoglobin production in sickle cell anemia in the eastern province of Saudi Arabia is genetically determined

S. Orkin, D. Weatherall, D. Nathan, 1986 .

Influence of hydroxyurea on fetal hemoglobin production in vitro.

O. Platt, D. Nathan, G. Dover, 1987, Blood.

Pharmacologic Manipulation of Fetal Hemoglobin in the Hemoglobinopathies a

D. Nathan, 1990, Annals of the New York Academy of Sciences.

Determination of the hemoglobin F program in human progenitor-derived erythroid cells.

D. Linch, J. Lipton, D. Nathan, 1985, The Journal of clinical investigation.

Regulation of erythropoiesis and hemoglobin F production.

D. Nathan, 1983, Progress in clinical and biological research.

Thalassemia: an overview of 50 years of clinical research.

V. Sankaran, D. Nathan, Vijay G Sankaran, 2010, Hematology/oncology clinics of North America.

Synthesis of hemoglobin F in adult simian erythroid progenitor-derived colonies.

R. Macklis, J. Lipton, D. Nathan, 1982, The Journal of clinical investigation.

F‐CELL REGULATION

B. Alter, D. Nathan, Blanche P. Alter, 1980, Annals of the New York Academy of Sciences.

Analysis of Hemoglobin F Production in Saudi Arabian Families With Sickle Cell Anemia

S. Orkin, N. Olivieri, D. Nathan, 1987 .

Editorial retrospective. Erythropoietin and the regulation of erythropoiesis.

A. Sytkowski, D. Nathan, 1983, The New England journal of medicine.

Control of the simian fetal hemoglobin switch at the progenitor cell level.

B. T. Jackson, B. Alter, J. Lipton, 1981, The Journal of clinical investigation.

Regulation of Fetal Hemoglobin Synthesis in the Hemoglobinopathies

D. Nathan, 1985, Annals of the New York Academy of Sciences.

Restoration of phagocyte function by interferon-gamma in X-linked chronic granulomatous disease occurs at the level of a progenitor cell.

S. Orkin, P. Newburger, M. Dinauer, 1990, Blood.

Hydroxyurea increases fetal hemoglobin production in sickle cell anemia.

S. Orkin, O. Platt, G. P. Beardsley, 1984, Transactions of the Association of American Physicians.

Investigations of the simian ontogenic switch from fetal to adult hemoglobin at the progenitor cell level.

B. T. Jackson, B. Alter, D. Linch, 1986, The Journal of clinical investigation.

Amino acid uptake in erythropoiesis

D. Nathan, 2015, Science Signaling.

Production in Sickle Cell Anemia

S. Orkin, G. P. Beardsley, D. Nathan, 1984 .

CULTURED CELLS IN MARROW TRANSPLANTATION 1113 recipients of cultured marrow cells with major H-2 histocompatibility differences

S. Hellman, J. Lipton, D. Nathan, 2005 .

Antibody-induced red cell aplasia.

D. Nathan, 1981, New England Journal of Medicine.

Survival in medically treated patients with homozygous beta-thalassemia.

J. H. MacMillan, G. Koren, N. Olivieri, 1994, The New England journal of medicine.

Antenatal diagnosis of thalassaemia major.

J. Clegg, D. Weatherall, B. Alter, 1978, British medical journal.

Relation of Beta to Gamma Synthesis During the First Trimester: An Approach to Prenatal Diagnosis of Thalassemia

Y. Kan, D. Nathan, F. Frigoletto, 1974, Pediatric Research.

Evidence for a clonal model for hemoglobin switching.

B. Alter, J. Lipton, D. Nathan, 1983, Progress in clinical and biological research.

Cell-cell interactions in in vitro erythropoiesis.

J. Lipton, D. Nathan, 1980, Blood cells.

Regulation of erythropoiesis.

D. Nathan, 1977, The New England journal of medicine.

Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia.

A. Beggs, L. D. Da Costa, C. Niemeyer, 2006, American journal of human genetics.

Nathan and Oski's hematology of infancy and childhood

S. Orkin, D. Nathan, 2013 .

Sickle cell disease (SCD), iNKT cells, and regadenoson infusion.

D. Neuberg, O. Onyekwere, J. Keefer, 2012, Transactions of the American Clinical and Climatological Association.

Congenital hemolytic anemia associated with dehydrated erythrocytes and increased potassium loss.

B. Glader, D. Nathan, N. Fortier, 1974, The New England journal of medicine.

Pulmonary hypertension and nitric oxide depletion in sickle cell disease.

O. Platt, R. Hebbel, R. Ware, 2010, Blood.

The role of red cell energy metabolism in the generation of irreversibly sickled cells in vitro.

S. Shohet, D. Nathan, M. Jensen, 1973, Blood.

The molecular genetics of thalassemia.

S. Orkin, D. Nathan, Stuart H. Orkin, 1981, Advances in human genetics.

LOCI OF HUMAN HÆMOGLOBIN GENES

D. Nathan, E. Schwartz, Donald W. Smith, 1967 .

Sickle cell disease and stroke.

D. Nathan, L. Verduzco, L. A. Verduzco, 2009, Blood.

Sickle cell disease and stroke Running Head: Left: VERDUZCO and NATHAN Right: SICKLE CELL DISEASE AND STROKE

D. Nathan, L. Verduzco, 2009 .

Response of three classes of human erythroid progenitors to the absence of erythropoietin in vitro as a measure of progenitor maturity.

J. Lipton, D. Nathan, M. Kudisch, 1981, Experimental hematology.

Androgens and erythropoiesis. 3. Further evaluation of testosterone treatment of myelofibrosis.

D. Nathan, F. Gardner, 1966, The New England journal of medicine.

Application of endonuclease mapping to the analysis and prenatal diagnosis of thalassemias caused by globin-gene deletion.

H. Lazarus, S. Orkin, J. Hobbins, 1978, The New England journal of medicine.

Manipulation of HbF production with hematopoietic growth factors.

A. Nienhuis, K. McDonagh, R. Donahue, 1989, Progress in clinical and biological research.

A Life-Long Quest to Understand and Treat Genetic Blood Disorders

D. Nathan, 2010, Cell.

Comparative study of the metabolic and bactericidal characteristics of severely glucose-6-phosphate dehydrogenase-deficient polymorphonuclear leukocytes and leukocytes from children with chronic granulomatous disease.

R. Johnston, D. Nathan, R. Baehner, 1972, Journal of the Reticuloendothelial Society.

Isolation of a human stromal cell strain secreting hemopoietic growth factors

S. Tsai, S. Emerson, D. Nathan, 1986, Journal of cellular physiology.

VAPA10: a treatment program for acute myelocytic leukemia.

D. Rosenthal, R. Mayer, D. Nathan, 1981, Haematology and blood transfusion.

The treatment of acute myelogenous leukemia in children and adults: VAPA update.

R. Gelber, D. Rosenthal, R. Mayer, 1983, Haematology and blood transfusion.

Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia.

E. Lander, S. Orkin, R. Do, 2012, The Journal of clinical investigation.

Sodium and potassium concentration and transmembrane fluxes in leukocytes.

D. Nathan, G. Cividalli, 1974, Blood.

Stromal CellAssociated CellAssociated CellAssociated Erythropoiesis By

S. Tsai, C. Sieff, D. Nathan, 2005 .

Megaloblastic hematopoiesis in uremia and in patients on long-term hemodialysis.

D. Nathan, J. Merrill, C. Hampers, 1967, The New England journal of medicine.

Life-span and organ sequestration of the red cells in pyruvate kinase deficiency.

F. Oski, D. Nathan, F. Gardner, 1968, The New England journal of medicine.

Confounding in ex vivo models of Diamond-Blackfan anemia.

Jacob C. Ulirsch, C. Lareau, N. Mohandas, 2017, Blood.

Evidence for linkage of familial Diamond-Blackfan anemia to chromosome 8p23.3-p22 and for non-19q non-8p disease.

M. Daly, A. Beggs, C. Niemeyer, 2001, Blood.

Acceptance of the 2006 Kober medal.

D. Nathan, 2007, The Journal of clinical investigation.

T‐cell acute lymphoblastic leukaemia with late developing Philadelphia chromosome

S. Sallan, J. Lipton, D. Nathan, 1984, British journal of haematology.

Congenital bone marrow failure syndromes.

D. Nathan, C. Sieff, E. Nisbet-Brown, 2000 .

Congenital bone marrow failure syndromes

D. Nathan, C. Sieff, E. Nisbet-Brown, 2000, British journal of haematology.

The counting of barium carbonate in a liquid scintillation spectrometer.

D. Nathan, J. D. Davidson, J. Waggoner, 1958, The Journal of laboratory and clinical medicine.

The Pathophysiology of Acquired Aplastic Anemia: Current Concepts Revisited.

D. Nathan, M. Schoettler, 2018, Hematology/oncology clinics of North America.

Rubbish in the red cell.

D. Nathan, 1969, The New England journal of medicine.

Congenital hemolytic anemia with high-sodium, low-potassium red cells. Studies of three generations of a family with a new variant.

J. Whaun, F. Oski, S. Shohet, 1969, The New England journal of medicine.

Exome sequencing identifies GATA 1 mutations resulting in Diamond-Blackfan anemia

E. Lander, S. Orkin, R. Do, 2012 .

lymphohematopoietic engraftment eradication of the PNH clone and documentation of complete Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria

S. Orkin, B. Smith, D. Ginsburg, 2011 .

Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria: eradication of the PNH clone and documentation of complete lymphohematopoietic engraftment

S. Orkin, B. Smith, D. Ginsburg, 1985 .

Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria: eradication of the PNH clone and documentation of complete lymphohematopoietic engraftment.

S. Orkin, D. Ginsburg, D. Nathan, 1985, Blood.

Bone marrow transplantation for an infant with neutrophil dysfunction.

T. Stossel, J. Cassady, D. Nathan, 1977, Experimental hematology.

Use of homologous platelet survival in differential diagnoses of chronic thrombocytopenia in childhood.

D. Nathan, G. Buchanan, L. Button, 1977, Pediatrics.

Efficacy of a cyclophosphamide-procarbazine-antithymocyte serum regimen for prevention of graft rejection following bone marrow transplantation for transfused patients with aplastic anemia.

E. Guinan, D. Nathan, B. Smith, 1985, Transplantation.

Musings on genome medicine: enzyme-replacement therapy of the lysosomal storage diseases

S. Orkin, D. Nathan, 2009, Genome Medicine.

Comparative metabolism of haemoglobins A and F in thalassaemia.

D. Nathan, F. Gardner, T. Gabuzda, 1962, Nature.

An Unusual Form of Chronic Neutropenia in a Father and Daughter with Hypogammaglobulinaemia

R. Johnston, D. Nathan, W. Mentzer, 1977, British journal of haematology.

Amino acid oxidase of leukocytes in relation to H 2 O 2 -mediated bacterial killing.

D. Nathan, R. Baehner, M. Eckstein, 1971, The Journal of clinical investigation.

Pathophysiology of common hemolytic syndromes.

D. Nathan, G. Segel, 1971, Postgraduate medicine.

Case 14-1968: Thalassemia in a Forty-Eight-Year-Old Man

B. U. Mcneely, B. Castleman, D. Nathan, 1968 .

Oral iron chelators.

S. Piomelli, D. Nathan, 1990, Seminars in hematology.

Granulocyte-macrophage colony-stimulating factor and interleukin-3 mRNAs are produced by a small fraction of blood mononuclear cells.

R. Arceci, C. Niemeyer, B. Mathey-Prevot, 1989, Blood.

New methods of counting of C-14-labeled hemoglobin and hemin.

D. Nathan, E. Schwartz, 1967, The Journal of laboratory and clinical medicine.

Reticulocyte survival in sickle cell anemia: effect of cyanate.

Y. Kan, B. Alter, D. Nathan, 1972, Blood.

Acute Hemodynamic Effects of Erythropheresis in 22 Patients with Severe Polycythemia Secondary to Cyanotic Congenital Heart Disease

A. Marty, A. Rosenthal, A. Nadas, 2005 .

Values for Intra cellular Content of Sod ium and Potassium in Leukocytes

D. Nathan, G. Cividalli, 2005 .

Toxic effects of high-dose cyanate administration in rodents.

Y. Kan, B. Alter, D. Nathan, 1974, Blood.

EXTREME HEMOLYSIS AND RED-CELL DISTORTION IN ERYTHROCYTE PYRUVATE KINASE DEFICIENCY. II. MEASUREMENTS OF ERYTHROCYTE GLUCOSE CONSUMPTION, POTASSIUM FLUX AND ADENOSINE TRIPHOSPHATE STABILITY.

F. Oski, D. Nathan, V. Sidel, 1965, The New England journal of medicine.

Bone marrow transplantation for thalassemia.

A. Nienhuis, D. Weatherall, S. Piomelli, 1987, The New England journal of medicine.

Pioneers and modern ideas. Prospective on thalassemia.

D. Nathan, 1998, Pediatrics.

EFFECT OF NEPHRECTOMY ON BLOOD-TRANSFUSION REQUIREMENTS

D. Nathan, 1969 .

NITROBLUE-TETRAZOLIUM TESTS

D. Nathan, 1975, The Lancet.

LIQUID SCINTILLATION COUNTING OF C14-LABELED HEMOGLOBIN AND HEMIN BY A MODIFIED SCHOENIGER TECHNIQUE.

D. Nathan, F. Gardner, T. Gabuzda, 1963, The Journal of laboratory and clinical medicine.

Antithoracic duct lymphocyte globulin.

D. Nathan, B. Camitta, R. O'reilly, 1983, Blood.

NIH support for basic and clinical research: biomedical researcher angst in 2006.

A. Schechter, D. Nathan, 2006, JAMA.

A colorimetric method for the measurement of the brain ammonia of the mouse; the effect of glutamine on the total measurable ammonia.

K. Warren, D. Nathan, 1959, Archives of biochemistry and biophysics.

Interleukin-3 expression by activated T cells involves an inducible, T-cell-specific factor and an octamer binding protein.

B. Mathey-Prevot, D. Nathan, K. Davies, 1993, Blood.

Anemia in adolescence. 2. Hemoglobinopathies and other causes.

D. Nathan, B. Camitta, 1975, Postgraduate medicine.

THALASSEMIA AS A PROLIFERATIVE DISORDER

D. Nathan, 1964, Medicine.

Hope for hematopoietic hormones.

D. Nathan, 1987, The New England journal of medicine.

Mild thalassemia--a guide to therapy.

D. Nathan, 1969, The New England journal of medicine.

Comprehensive Cancer Centres and the war on cancer

D. Nathan, E. Benz, 2001, Nature Reviews Cancer.

Effects of cyanate and 2,3-diphosphoglycerate on sickling. Relationship to oxygenation.

Y. Kan, D. Nathan, H. Bunn, 1973, The Journal of clinical investigation.

Extreme Hemolysis and Red-Cell Distortion in Erythrocyte Pyruvate Kinase Deficiency

F. Oski, D. Nathan, V. Sidel, 1964 .

EXTREME HEMOLYSIS AND RED-CELL DISTORTION IN ERYTHROCYTE PYRUVATE KINASE DEFICIENCY. I. MORPHOLOGY, ERYTHROKINETICS AND FAMILY ENZYME STUDIES.

F. Oski, D. Nathan, V. Sidel, 1964, The New England journal of medicine.

Exercise-induced hemolysis in xerocytosis. Erythrocyte dehydration and shear sensitivity.

O. Platt, D. Nathan, S. Lux, 1981, The Journal of clinical investigation.

Correction: NF-κB Is Activated in CD4+ iNKT Cells by Sickle Cell Disease and Mediates Rapid Induction of Adenosine A2A Receptors

J. Linden, D. Nathan, Joshua J Field, 2015, PloS one.

Globin Chain Synthesis in the

D. Nathan, 1968 .

Intracellular univalent cations and the regulation of the BALB/c-3T3 cell cycle

D. Nathan, C. Frantz, C. Scher, 1981, The Journal of cell biology.

INTRAUTERINE DIAGNOSIS OF THALASSEMIA

Y. Kan, D. Nathan, F. Frigoletto, 1974, Annals of the New York Academy of Sciences.

The Genetic Landscape of Diamond-Blackfan Anemia.

Beryl B. Cummings, Jacob C. Ulirsch, Michael H. Guo, 2019, American journal of human genetics.

The biological activities and uses of recombinant granulocyte-macrophage and multi-colony stimulating factors.

C. Sieff, D. Nathan, 1987, Progress in hematology.

Screening for sickle-cell trait and G-6-PD deficiency.

D. Nathan, B. Lubin, W. Mentzer, 1970, The New England journal of medicine.

Buffy-coat observations and red-cell antibodies in acquired hemolytic anemia.

E. Gelfand, D. Nathan, G. Segel, 1971, The New England journal of medicine.

Acute hemodynamic effects of red cell phoresis in secondary polycythemia with cyanotic congenital heart disease

A. Marty, A. Rosenthal, A. Nadas, 1969 .

A memory of Frank A. Oski

D. Nathan, 1997, Current opinion in pediatrics.

A cellular model for hemoglobin switching.

B. Alter, D. Nathan, 1982, Birth defects original article series.

Prenatal diagnosis of sickle-cell anemia and alpha G Philadelphia. Study of a Fetus also at risk for H b S/beta+-thalassemia.

J. Hobbins, B. Alter, D. Nathan, 1976, The New England journal of medicine.

The thalassemias.

S. Orkin, D. Nathan, 1976, The New England journal of medicine.

The reaction of cyanate with the alpha and beta subunits in hemoglobin. Effects of oxygenation, phosphates, and carbon dioxide.

D. Nathan, H. Bunn, M. Jensen, 1973, The Journal of biological chemistry.

Oxygen affinity independent action of cyanate and 2,3 DPG on sickling.

D. Nathan, H. Bunn, G. Halikas, 1972, Advances in experimental medicine and biology.

The role of red blood cell organic phosphates in adaptation to congenital heart disease.

A. Rosenthal, A. Nadas, D. Nathan, 1971, Pediatrics.

Hemoglobin F and beta thalassemia.

D. Nathan, F. Gardner, M. Kreimer‐Birnbaum, 1967, Science.

Hemoglobin F and Beta Thalassemia

D. Nathan, F. Gardner, T. Gabuzda, 1967, Science.

Prospective on Thalassemia

D. Nathan, 1998, Pediatrics.

Hemoglobin disorders: a look to the future.

D. Nathan, 2013, Blood.

Lethal graft-versus-host disease: modification with allogeneic cultured donor cells.

S. Hellman, J. Lipton, D. Nathan, 1984, Blood.

Reduction of lethal graft-versus-host disease: transplantation of cultured murine bone marrow across minor histocompatibility differences

S. Hellman, J. Lipton, D. Nathan, 1985 .

Careers chosen by graduates of a major pediatrics residency program, 1974‐1986

F. Lovejoy, D. Nathan, 1992, Academic medicine : journal of the Association of American Medical Colleges.

Clinical research: perceptions, reality, and proposed solutions. National Institutes of Health Director's Panel on Clinical Research.

D. Nathan, 1998, JAMA.

Regulation of fetal hemoglobin synthesis by cell cycle specific drugs.

D. Nathan, 1985, Progress in clinical and biological research.

Normal and variant isoenzymes of human blood cell hexokinase and the isoenzyme patterns in hemolytic anemia.

D. Nathan, C. Alper, Ç. Altay, 1970, Blood.

Antithoracic duct lymphocyte globulin [letter]

D. Nathan, B. Camitta, R. O'reilly, 1983 .

Studies of the rate of production and life span of erythrocytes in acute leukemia.

D. Nathan, N. Berlin, 1959, Blood.

Musings on genome medicine: Crohn's disease

S. Orkin, D. Nathan, 2009, Genome Medicine.

Blood Relations: Transfusion and the Making of Human Genetics Jenny Bangham Chicago, IL: University of Chicago Press, 2020

D. Nathan, 2021 .

Iron chelation with oral deferiprone in patients with thalassemia.

D. Weatherall, D. Nathan, 1998, New England Journal of Medicine.

Molecular pathology of the thalassemias.

D. Nathan, B. Forget, 1976, Advances in internal medicine.

The Jeremiah Metzger lecture. Regulation of hematopoiesis.

D. Nathan, 1990, Transactions of the American Clinical and Climatological Association.

The beneficence of neonatal hematopoiesis.

D. Nathan, 1989, The New England journal of medicine.

Analysis of high fetal hemoglobin production in sickle cell anemia patients from the Eastern Province of Saudi Arabia.

S. Orkin, N. Olivieri, D. Nathan, 1987, Progress in clinical and biological research.

Expression of the beta-thalassemia gene in the first trimester fetus.

B. Alter, D. Nathan, E. Huehns, 1975, Proceedings of the National Academy of Sciences of the United States of America.

Decreased hematopoietic accessory cell function following bone marrow transplantation.

R. Miller, C. Sieff, S. Emerson, 1987, Experimental Hematology.

Eulogy for the clinical research center.

D. Nathan, D. Nathan, 2016, The Journal of clinical investigation.

Advances in Sickle Cell Therapies in the Hydroxyurea Era

D. Nathan, Joshua J Field, 2014, Molecular medicine.

Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality.

R. Storb, R. Gale, D. Nathan, 1976, Blood.

Hemoglobin disorders: a look to the future.

D. Nathan, 2013, Blood.

addition of erythropoietin on circulating erythroid progenitors using an assay involving the delayed Demonstration of burst-promoting activity of recombinant human GM-CSF

S. Clark, S. Emerson, D. Nathan, 2011 .

Musings on genome medicine: the slow but inexorable process of medical care reform in the United States

S. Orkin, D. Nathan, 2009, Genome Medicine.

Clinical research: perceptions, reality, and proposed solutions. National Institutes of Health Director's Panel on Clinical Research.

D. Nathan, 1998, JAMA.